Revised algorithm for heparin anticoagulation during continuous renal replacement therapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1364-8535
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Revised algorithm for heparin anticoagulation during continuous renal replacement therapy ; volume:19 ; number:1 ; day:1 ; month:12 ; year:2015 ; pages:1-2 ; date:12.2015
Critical care ; 19, Heft 1 (1.12.2015), 1-2, 12.2015
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13054-015-1099-y
- URN
-
urn:nbn:de:101:1-2021102920242270952202
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Dickie, Helen
- Tovey, Linda
- Berry, William
- Ostermann, Marlies
- SpringerLink (Online service)
Other Objects (12)
Citrate anticoagulation and systemic heparin anticoagulation during continuous renal replacement therapy among critically-ill children
Citrate versus heparin anticoagulation in continuous renal replacement therapy in small children
Citrate and low-dose heparin combined anticoagulation in pediatric continuous renal replacement therapy
Unfractionated heparin versus nafamostat mesylate for anticoagulation during continuous kidney replacement therapy: an observational study
Correction: Unfractionated heparin versus nafamostat mesylate for anticoagulation during continuous kidney replacement therapy: an observational study
Continuous kidney replacement therapy in critically ill children: heparin vs citrate
Complications of Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy: An Observational Study
Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis with trial sequential analysis of randomized controlled trials
Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: a randomized controlled trial
Low bicarbonate replacement fluid normalizes metabolic alkalosis during continuous veno-venous hemofiltration with regional citrate anticoagulation
Heparin-Induced Thrombocytopenia in Healthy Individuals with Continuous Heparin Infusion
Analysis of Anticoagulation Activities of Heparins - Is usp Heparin Assay Reliable?
Citrate anticoagulation and systemic heparin anticoagulation during continuous renal replacement therapy among critically-ill children
Citrate versus heparin anticoagulation in continuous renal replacement therapy in small children
Citrate and low-dose heparin combined anticoagulation in pediatric continuous renal replacement therapy
Unfractionated heparin versus nafamostat mesylate for anticoagulation during continuous kidney replacement therapy: an observational study
Correction: Unfractionated heparin versus nafamostat mesylate for anticoagulation during continuous kidney replacement therapy: an observational study
Continuous kidney replacement therapy in critically ill children: heparin vs citrate
Complications of Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy: An Observational Study
Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis with trial sequential analysis of randomized controlled trials
Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: a randomized controlled trial
Low bicarbonate replacement fluid normalizes metabolic alkalosis during continuous veno-venous hemofiltration with regional citrate anticoagulation
Heparin-Induced Thrombocytopenia in Healthy Individuals with Continuous Heparin Infusion
Analysis of Anticoagulation Activities of Heparins - Is usp Heparin Assay Reliable?
Citrate anticoagulation and systemic heparin anticoagulation during continuous renal replacement therapy among critically-ill children
Citrate versus heparin anticoagulation in continuous renal replacement therapy in small children
Citrate and low-dose heparin combined anticoagulation in pediatric continuous renal replacement therapy
Unfractionated heparin versus nafamostat mesylate for anticoagulation during continuous kidney replacement therapy: an observational study
Correction: Unfractionated heparin versus nafamostat mesylate for anticoagulation during continuous kidney replacement therapy: an observational study
Continuous kidney replacement therapy in critically ill children: heparin vs citrate
Complications of Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy: An Observational Study
Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis with trial sequential analysis of randomized controlled trials
Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: a randomized controlled trial
Low bicarbonate replacement fluid normalizes metabolic alkalosis during continuous veno-venous hemofiltration with regional citrate anticoagulation
Heparin-Induced Thrombocytopenia in Healthy Individuals with Continuous Heparin Infusion